Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ian Parr is active.

Publication


Featured researches published by Ian Parr.


Bioorganic & Medicinal Chemistry Letters | 2017

Structure-based discovery of LpxC inhibitors

Jing Zhang; Audrey Chan; Blaise Lippa; Jason B. Cross; Christopher Liu; Ning Yin; Jan Romero; Jonathan Lawrence; Ryan Heney; Prudencio Herradura; Jennifer Goss; Cynthia Clark; Cassandra Abel; Yanzhi Zhang; Katherine M. Poutsiaka; Felix Epie; Mary Conrad; Azard Mahamoon; Kien T. Nguyen; Ajit Chavan; Edward Clark; Tongchuan Li; Robert K. Y. Cheng; Michael W. Wood; Ole Andreas Andersen; Mark Brooks; Jason Kwong; John J. Barker; Ian Parr; Yugui Gu

The emergence and spread of multidrug-resistant (MDR) Gram negative bacteria presents a serious threat for public health. Novel antimicrobials that could overcome the resistance problems are urgently needed. UDP-3-O-(R-3-hydroxymyristol)-N-acetylglucosamine deacetylase (LpxC) is a cytosolic zinc-based deacetylase that catalyzes the first committed step in the biosynthesis of lipid A, which is essential for the survival of Gram-negative bacteria. Our efforts toward the discovery of novel LpxC inhibitors are presented herein.


Archive | 2000

Lipopeptides as antibacterial agents

Jason Hill; Ian Parr; Michael Morytko; Jim Siedlecki; Xiang Yang Yu; Jared Silverman; Dennis Keith; John T. Finn; Dale J. Christensen; Tsvetelina Lazarova; Alan D. Watson; Yan Zhang


Bioorganic & Medicinal Chemistry Letters | 2003

Synthesis and biological activity of N-Acylated ornithine analogues of daptomycin.

Jason Hill; James Siedlecki; Ian Parr; Michael Morytko; Xiang Yu; Yanzhi Zhang; Jared Silverman; Nicole Controneo; Valerie Laganas; Tongchuan Li; Dennis Keith; George Shimer; John T. Finn


Archive | 2000

Novel lipopeptides as antibacterial agents

Jason Hill; Ian Parr; Michael Morytko; Jim Siedlecki; Xiang Yang Yu; Jared Silverman; Dennis Keith; John Finn; Dale J. Christensen; Tsvetelina Lazarova; Alan D. Watson; Yan Zhang


Bioorganic & Medicinal Chemistry Letters | 2003

Array synthesis of novel lipodepsipeptide

James Siedlecki; Jason Hill; Ian Parr; Xiang Yu; Michael Morytko; Yanzhi Zhang; Jared Silverman; Nicole Controneo; Valerie Laganas; Tongchuan Li; Jianshi Li; Dennis Keith; George Shimer; John T. Finn


Archive | 2002

NOVEL DEPSIPEPTIDES AND PROCESS FOR PREPARING SAME

John T. Finn; Michael Morytko; Ian Parr; Michael E. Jung


Archive | 2000

Daptomycin analogs as antibacterial agents

Jason Hill; Ian Parr; Michael Morytko; Jim Siedlecki; Xiang Yang Yu; Jared Silverman; Dennis Keith; John T. Finn; Dale J. Christensen; Tsvetelina Lazarova; Alan D. Watson; Yan Zhang


Archive | 2012

Daptomycin analog as antibacterial agent

Dale J. Christensen; John Finn; Jason Hill; Dennis Keith; Tsvetelina Lazarova; Michael Morytko; Ian Parr; Jim Siedlecki; Jared Silverman; Alan D. Watson; Xiang Yang Yu; Yan Zhang; アラン ディー. ワトソン,; イアン パール; ジェイソン ヒル; ジム シードレッキ; ジャレッド シルバーマン; シャン ヤン ユ; ジョン フィン; ツヴェテリナ ラザロヴァ; デイル クリステンセン; デニス ケイス; マイケル モリトコ; ヤン チャン


Archive | 2002

Nouveaux depsipeptides et leur procede de preparation

John Finn; Michael E. Jung; Michael Morytko; Ian Parr


Archive | 2000

Daptomycin analogs and their use as antibacterial agents

Dale J. Christensen; John Finn; Jason Hill; Dennis Keith; Tsvetelina Lazarova; Michael Morytko; Ian Parr; Jim Siedlecki; Jared Silverman; Alan D. Watson; Xiang Yang Yu; Yan Zhang

Collaboration


Dive into the Ian Parr's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jason Hill

Cubist Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yan Zhang

Cubist Pharmaceuticals

View shared research outputs
Researchain Logo
Decentralizing Knowledge